Warning: Declaration of IPW_Primary_Nav_Walker::start_el(&$output, $item, $depth, $args) should be compatible with Walker_Nav_Menu::start_el(&$output, $item, $depth = 0, $args = Array, $id = 0) in /home/ipwatch/public_html/wp-content/themes/ipwatchdog/lib/nav-walker-dropdown.php on line 0

Warning: Declaration of IPW_Primary_Nav_Walker_Dropdown::start_lvl(&$output, $depth, $args) should be compatible with Walker_Nav_Menu::start_lvl(&$output, $depth = 0, $args = Array) in /home/ipwatch/public_html/wp-content/themes/ipwatchdog/lib/nav-walker-dropdown.php on line 0

Warning: Declaration of IPW_Primary_Nav_Walker_Dropdown::end_lvl(&$output, $depth, $args) should be compatible with Walker_Nav_Menu::end_lvl(&$output, $depth = 0, $args = Array) in /home/ipwatch/public_html/wp-content/themes/ipwatchdog/lib/nav-walker-dropdown.php on line 0
Henry Shikani, Author at IPWatchdog.com | Patents & Patent Law

Henry Shikani

Carla Mouta-Bellum

Henry Shikani is a Technical Specialist at Finnegan who focuses his practice on patent prosecution, post-grant proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO), and patent litigation in the chemical, pharmaceutical, medical device, and biotechnology fields. His experience includes assisting with Abbreviated New Drug Application (ANDA) litigations under the Hatch-Waxman Act, inter partes review (IPR) trials, and interference proceedings.

For more information, or to contact Dr. Shikani, please visit his Firm Profile Page


Posts by Henry Shikani


The Immunotherapy Patent Landscape: Types of patent claims for immunotherapeutic inventions

Immunotherapy has emerged as one of the most promising mechanisms to combat diseases like cancer and microbial infections. Since 2000, multiple antibody drugs have reached blockbuster status, including …